[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362098-105":59,"doc-detail-362098-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunohistochemical-classification-of-high-grade-pancreatic-intraepithelial-neoplasia-and-ductal-cancerization-p53-smad4-and-mucin-expression","Immunohistochemical Classification of High-Grade Pancreatic Intraepithelial Neoplasia and Ductal Cancerization - p53, SMAD4, and Mucin Expression","","Study aimed to determine frequencies of high-grade pancreatic intraepithelial lesions (HG-PanIN) and ductal cancerization (COD), defined as spread of invasive cancer within the pancreatic duct, and to compare mucin profiles in pancreatic ductal adenocarcinoma. Immunohistochemistry for p53, SMAD4, and mucin was performed on 103 lesions in 97 cases. CIS with p53/SMAD4 patterns distinct from invasive carcinoma was classified as HG-PanIN, whereas CIS matching invasive profiles was classified as COD. CIS lesions were mainly COD (63; 61.2%) versus HG-PanIN (29; 28.2%). CODs showed aberrant p53 and SMAD4 in 30 lesions (47.6%). MUC1 and MUC6 distributions differed between COD/HG-PanIN and invasive carcinoma.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunohistochemical-classification-of-high-grade-pancreatic-intraepithelial-neoplasia-and-ductal-cancerization-p53-smad4-and-mucin-expression/362098/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunohistochemical-classification-of-high-grade-pancreatic-intraepithelial-neoplasia-and-ductal-cancerization-p53-smad4-and-mucin-expression/362098.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were CIS lesions classified in this study?","Question",{"text":112,"@type":113},"CIS with p53 and SMAD4 staining patterns different from invasive carcinoma was classified as HG-PanIN. CIS with staining consistent with invasive carcinoma was classified as COD.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What proportion of CIS lesions were COD versus HG-PanIN?",{"text":117,"@type":113},"CIS lesions were classified as 63 COD (61.2%) and 29 HG-PanIN (28.2%).",{"name":119,"@type":110,"acceptedAnswer":120},"Which mucins showed differential expression between COD/HG-PanIN and invasive carcinoma?",{"text":121,"@type":113},"MUC1 positivity was lower in COD and HG-PanIN than in invasive carcinoma. MUC6 was also differentially expressed, with higher positivity in HG-PanIN compared with invasive carcinoma and COD.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362098,1790212211,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Journal of Pathology, Microbiology and Immunology  \nORIGINAL ARTICLE  OPEN ACCESS   \nImmunohistochemical Classification of High-Grade Pancreatic Intraepithelial Neoplasia and Ductal Cancerization in Pancreatic Ductal Adenocarcinoma Using p53, SMAD4, and Mucin Expression  \nYumi Nozawa-Yoshimura1 | Kazuyuki Ishida1  | Masato Onozaki1 | Akihiro Kawabe1 | Taku Aoki2  \n1Department of Diagnostic Pathology, Dokkyo Medical University, Mibu, Tochigi, Japan | 2Department of Hepato-Biliary-Pancreatic Surgery, Dokkyo Medical University, Mibu, Tochigi, Japan  \nCorrespondence: Kazuyuki Ishida ([ishida-k@dokkyomed.ac.jp](ishida-k@dokkyomed.ac.jp))  \nReceived: 13 June 2025 | Revised: 27 October 2025 | Accepted: 17 November 2025  \nKeywords: cancerization of ducts | molecular abnormalities | mucin expression | pancreatic ductal adenocarcinoma | pancreatic intraepithelial lesions  \nABSTRACT  \nThis study was conducted to determine the frequency of high-grade pancreatic intraepithelial lesions (HG-PanIN) and the cancerization of ducts (COD), a phenomenon in which invasive cancer spreads within the pancreatic duct, and the differences between mucous profiles in pancreatic ductal adenocarcinoma. Immunohistochemistry for p53, SMAD4 and mucin was performed on 103 lesions in 97 cases. Carcinoma in situ (CIS) with p53 and SMAD4 staining that were different from invasive carcinoma were classified as HG-PanIN, while CIS with staining consistent with invasive carcinoma were classified as COD. CIS lesions were classified as 63 COD (61.2%) and 29 HG-PanIN (28.2%) . The CODs consisted of 30 lesions (47.6%) with aberrant p53 and SMAD4, 26 lesions (41.3%) with aberrant p53, and 7 lesions (11.1%) with aberrant SMAD4. Fourteen HG-PanIN lesions (48.3%) had aberrant p53. MUC1 positivity was lower in COD (27 lesions; 42.9%) and HG-PanIN (16 lesions; 55.2%) than in invasive carcinoma (81 lesions; 83.5%) (p \u003C 0.01) . MUC6 was positive in 17 HG-PanIN lesions (58.6%)—higher than in invasive carcinoma (18 lesions; 18.6%) and COD (8 lesions; 12.7%) (p \u003C 0.001) . This study classified CIS as COD and HG-PanIN and found that the MUC6 expression of COD and HG-PanIN differed.  \n1 | Introduction  \nPancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant neoplasm with a dismal prognosis [1]. PDAC is generally characterized by four gene mutations: oncogenic KRAS mutations, and inactivation of the tumor suppressor genes, CDKN2A, TP53, and SMAD4 [1, 2] . Numerous other genes are mutated in subsets of PDACs, but usually at very low frequencies [3] . Pancreatic intraepithelial neoplasia (PanIN) is defined as noninvasive pancreatic intraductal proliferation and is considered a precursor of PDAC [4, 5] . PanINs are classified as low grade or high grade, and high-grade PanINs (HG-PanINs) are of high clinical significance due to the risk of progression to PDACs.  \nIn PanINs, the activation of KRAS mutations, an early genetic change in the development of PDACs, is observed in more than 90% of low-grade PanINs (LG-PanINs) [6] . CDK2NA, TP53 and SMAD4 promote tumor growth, with CDK2NA mutations found in LG-PanINs after the appearance of oncogenic KRAS mutations, and TP53, and SMAD4 found mainly in HG-PanINs and invasive cancer carcinomas [3–7] .  \nMucin (MUC) glycoproteins are superior in discriminating PDAC from chronic pancreatitis and normal pancreas, and an immunohistochemical staining panel of MUC is expected to improve the diagnostic performance of pancreatic endoscopic ultrasound-guided fine needle aspiration biopsy [8] .  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2025 The Author(s). APMIS published by John Wiley & Sons Ltd on behalf of APMIS-Journal of Pathology, Microbiology and Immunology.  \nAPMIS, 2025; 133:e70106 1 of 9  \n[http","cbCaiow1Dx2jb0EY","https://ap.wps.com/l/cbCaiow1Dx2jb0EY","pdf",1525398,"English","# Introduction\n# Materials and Methods\n# Results\n## Frequency of HG-PanIN and COD\n## p53 and SMAD4 expression patterns\n## Mucin (MUC1/MUC6) expression differences\n# Discussion","[{\"question\":\"How were CIS lesions classified in this study?\",\"answer\":\"CIS with p53 and SMAD4 staining patterns different from invasive carcinoma was classified as HG-PanIN. CIS with staining consistent with invasive carcinoma was classified as COD.\"},{\"question\":\"What proportion of CIS lesions were COD versus HG-PanIN?\",\"answer\":\"CIS lesions were classified as 63 COD (61.2%) and 29 HG-PanIN (28.2%).\"},{\"question\":\"Which mucins showed differential expression between COD/HG-PanIN and invasive carcinoma?\",\"answer\":\"MUC1 positivity was lower in COD and HG-PanIN than in invasive carcinoma. MUC6 was also differentially expressed, with higher positivity in HG-PanIN compared with invasive carcinoma and COD.\"}]","Immunohistochemical Classification of High-Grade Pancreatic Intraepithelial Neoplasia and Ductal Cancerization - p53, SMAD4, and Mucin Expression | PDF",1790146471,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/068f145fa356d435cc88ff7eb96814b0.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc58020a3194fdd9ffd52c81737d7346.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fed917721a9b81530c96e6c39433fc3a.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cabedcc3bf7f8f4b59a03e25e2a260df.webp",980,1287]